CPI appointed Steve Bagshaw as a non-executive director.
He brings a wealth of experience from leadership roles in pharmaceutical manufacturing and industrial biotechnology.
Bagshaw initially trained as a chemical engineer in Manchester and held roles including CEO of FUJIFILM Diosynth Biotechnologies, president of Avecia Biologics Ltd and business director at MSD Biologics.
In 2011, he joined FUJIFILM Diosynth Biotechnologies as managing director and became CEO of the company in 2014.
Also, Bagshaw has chaired the UK's Industrial Biotechnology Leadership Forum since 2013 and took on a role as co-chair of the UK Bioeconomy Strategy Board in 2016.
In his role as non-executive director, he will work closely with CPI’s leadership team on the company’s long-term strategy to create strong models of collaboration that drive innovation.
Bagshaw will support CPI by leveraging his experience and ability to build networks with stakeholders in the public and private sectors, which will strengthen CPI’s ability to accelerate the commercialization of innovative products and processes.
“I’m delighted to take on this new role at CPI. As CPI has grown over the last decade, it has demonstrated time and time again how collaboration between government, academia and industry can drive innovation," he said.
“As we press forward with our strategy to accelerate the opportunities for innovation in the pharmaceutical industry, Steve will play an important role in developing our strategy, bringing together stakeholders and fostering partnerships," added Frank Millar, CPI CEO.
